Clinical trials
Withdrawn Neoplasm Metastasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| SCRI Development Innovations, LLC | 3 |
| Case Comprehensive Cancer Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| NYU Langone Health | 2 |
| The Methodist Hospital Research Institute | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| Turning Point Therapeutics, Inc. | 2 |
| University of Kansas Medical Center | 2 |
| Actuate Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 55 |
| Neoplasms | 10 |
| Breast Neoplasms | 8 |
| Brain Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Lung Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Adenocarcinoma | 4 |
| Colonic Neoplasms | 3 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.